发明名称 TAIL VARIANTS OF REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND ASSOCIATED ASPECTS AND MODULATION OF ENERGY BIOMARKERS
摘要 PROBLEM TO BE SOLVED: To provide compositions and methods useful in treating or suppressing diseases due to mitochondrial diseases, such as Friedreich's ataxia, Leber's Hereditary Optic Neuropathy, Kearns-Sayre Syndrome, and mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), and modulating energy biomarkers in a subject.SOLUTION: The invention provides compounds useful in treating or suppressing mitochondrial diseases, and methods of using such compounds for modulating energy biomarkers. The redox active therapy for treatment or suppression of mitochondrial diseases and associated aspects of the invention are described in more detail herein.SELECTED DRAWING: None
申请公布号 JP2016040311(A) 申请公布日期 2016.03.24
申请号 JP20150223653 申请日期 2015.11.16
申请人 EDISON PHARMACEUTICALS INC 发明人 MILLER GUY M;HECHT SIDNEY M
分类号 A61K31/05;A61K31/122;A61P3/10;A61P3/12;A61P9/00;A61P11/00;A61P13/02;A61P21/00;A61P25/00;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/28;A61P27/02;A61P31/06;A61P35/00;A61P43/00 主分类号 A61K31/05
代理机构 代理人
主权项
地址